Genotek
PrivateLast Round
VC Round
Dec 23, 2020
Est. Valuation
$5.71M
Total Funding Raised
$2.5M
Company Overview
Genotek operates in Healthcare & Life Sciences and is based in Moscow. Its latest recorded funding round was a VC Round in December 2020.
Genotek is a biotechnology company that provides a platform for DNA testing services designed to give clients access to their genetic information.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Telemedicine
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genotek Comparables
Compare Genotek with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| National Center for Genetic Research | 83% | |
| GenePlanet | 77% | |
| Mapmygenome | 74% |
For institutional investors. Book with your work email.
Genotek Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 23, 2020 | ||||
| VC Round | Dec 30, 2016 | ||||
| Angel | Feb 10, 2016 | ||||
| Seed | Sep 1, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genotek Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pharmstandard | VC Round |
| Yandex | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Grew 17% QoQ, from 46 to 54 employees.
- Mar 4, 2026
Grew 20% QoQ, from 44 to 53 employees.
For institutional investors. Book with your work email.
Genotek Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genotek's valuation, stock price, and market status.
Is Genotek a public or private company?
Genotek is a private company.
What is the current stock price of Genotek?
Genotek is a private company, so its shares have no public market price. Caplight tracks Genotek's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genotek worth (valuation)?
Genotek's valuation is estimated at $5.7M based on funding round data.
Can I buy Genotek stock?
Genotek shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genotek's last funding round?
Genotek's most recent funding round was VC Round on December 23, 2020.
Who are the main investors in Genotek?
Key investors in Genotek include Pharmstandard, Yandex.
Will Genotek IPO soon?
No public IPO plans have been announced for Genotek.
How can I track Genotek secondary market activity?
Caplight tracks bids, offers, and trades in Genotek's shares on secondary markets.